Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression

Background. The aim of the study was to search for the existence of, and define, a possible relationship between performance in neuropsychological tests and baseline concentrations of plasma cortisol, vasopressin and oxytocin in medication-free patients with a major depressive episode. Methods. Measures of depression and anxiety were obtained and a neuropsychological battery was presented. Blood for neuropeptide analysis was drawn by venepuncture at 8.00, 16.00 and 23.00 h. Results. The melancholic patients performed less well on the neuropsychological battery than did the non-melancholic patients, but these differences could be accounted for by the severity of the illness. Global intellectual functioning was negatively correlated with mean baseline plasma concentrations of cortisol. Patients with high mean plasma vasopressin concentrations remembered more auditory presented words in the delayed recall test and produced more intrusions in the visual word learning list than did patients with low or normal mean plasma vasopressin concentrations. No association was found between neuropsychological performance and plasma concentrations of oxytocin. Conclusions. Our findings support the hypothesis that elevated baseline plasma cortisol concentrations are related to cognitive impairment in depressed patients and the hypothesis that the neuropeptide vasopressin independently enhances memory, directly or indirectly through increasing arousal and attention.

[1]  G. Kerkhof,et al.  Plasma arginine vasopressin and motor activity in major depression , 1998, Biological Psychiatry.

[2]  V. Wiegant,et al.  Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression , 1997, Neuropsychopharmacology.

[3]  A. Mitchell The contribution of hypercortisolaemia to the cognitive decline of geriatric depression , 1995 .

[4]  C. Vázquez,et al.  Automatic and effortful processing in depression. , 1993, Psychological bulletin.

[5]  G. Gessa,et al.  Central functions of oxytocin , 1991, Neuroscience & Biobehavioral Reviews.

[6]  R. Roos,et al.  Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type. , 1990, Archives of neurology.

[7]  A. Kumar,et al.  Influence of desglycinamide-(arg8) vasopressin on memory in healthy subjects. , 1990, Neuropsychobiology.

[8]  A. Jennekens‐Schinkel,et al.  A clinical trial with desglycinamide arginine vasopressin for the treatment of memory disorders in man , 1985, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  T. Higuchi,et al.  Release of oxytocin during suckling and parturition in the rat. , 1985, The Journal of endocrinology.

[10]  D. Cicchetti,et al.  The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[11]  V. Reus Hormonal mediation of the memory disorder in depression , 1984 .

[12]  E. Caine,et al.  Cognitive function and the dexamethasone suppression test in depression. , 1984, The American journal of psychiatry.

[13]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[14]  M. Åsberg,et al.  A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE , 1978, Acta psychiatrica Scandinavica. Supplementum.